
CAR T Therapy Cost Control With Laurence Cooper, M.D., Ph.D.
Business Of Biotech
00:00
Zire Farm: The Disruptor and Winner in the Field
In a commercial environment you've progressed with the therapy, you're able to scale it for commercial use. What does that look like? Is it still sort of a hospital lab? Is it an operation or do you produce at scale in a large production facility? Yeah. It could go a couple of different ways. The way we begin to scope out Zire Farm to be the disruptor is what would it take then to make blood banks into sites of T cell production? This is a very powerful and scalable vision because blood bankers are really good. They actually do GMP. We never think about them doing good manufacturing practice, but they do.
Play episode from 26:20
Transcript


